1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Cone Dystrophy 3: new trials by email Literature Review of Cone Dystrophy 3 trials Research Report on Cone Dystrophy 3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer Gemcitabine, Carboplatin, Panitumumab - Bladder Cancer | Phase 2 | Terminated | Memorial Sloan Kettering Cancer Center | 4 | 2013-08-01 | 2016-02-12 |
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Urinary Bladder Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
Carboplatin (1) · Cystectomy (1) · Gemcitabine (1) · Panitumumab (1)
Memorial Sloan Kettering Cancer Center (1)
United States (1)
Dean Bajorin, MD (1)